Current vaccine strains show high neutralization against the latest variants, but the LP.8.1 antigen may provide similar or moderately higher cross-reactive antibody response.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
Upwards of 700,000—perhaps as many as 1.6 million—US COVID-19 survivors haven't recovered their sense of smell after more than 6 months, according to a research letter yesterday in JAMA Otolaryngology-Head & Neck Surgery.
COVID-19 interventions might worsen loneliness, financial stress, and other mental health issues.
Austria, Germany, and the Netherlands all report record high daily cases.
Kansas, Louisiana, Maine, and Rhode Island become the latest to expand eligibility for COVID-19 boosters.
The US Centers for Disease Control and Prevention (CDC) published a new comprehensive survey of vaccine uptake in healthcare workers (HCWs), showing that after initial enthusiasm, vaccine uptake stalled at 70% by Sep 15, 2021. Results of the survey are published in the American Journal of Infection Control.
Data show that people taking immunosuppressive drugs, including cancer patients, are not at higher risk.
By the end of today 2.6 million young American children will have gotten their first shot.
For the 4th week in a row, the rate of new global COVID-19 cases rose, led by surges in Europe.
New research from the Mayo Clinic shows monoclonal antibodies reduce the risk of hospitalization 77% in 1,395 patients who had breakthrough COVID-19 infections. The research was published yesterday in the Journal of Infectious Diseases.
Pfizer has applied for emergency use authorization from the FDA for Paxlovid, its COVID-19 drug.
